Welcome to our annual Elysium tour, in which we electronically acknowledge the sweet nectar of victory flowing from the top ten drug/device product liability decisions of the year. It’s time to salute those fortunate decisions that brought the judicial Midas touch to our clients’ cases. We echo what we said last year: “we’re looking
You know it’s coming. It’s unavoidable, but necessary. We don’t like it any more than you do, but it’s that time of year. Time to recapitulate the worst punishments that the denizens of the you-know-where tort Tartari have inflicted upon our clients and us in 2019. Every year we contemplate our Sisyphean labors facing the
Ending the year on a high note is one thing that the Blog tries to do – with the top ten drug/device product liability decisions of the year. Occasionally, a court will do something that ruins the party, with an eleventh-hour awful decision (the infamous Bausch v. Stryker Corp., 630 F.3d 546 (7th Cir.
When we’re trying to decide whether to see a movie, one place we turn for advice is the Rotten Tomatoes website. We visited the site recently to see what those purveyors of overripe fruit had to say about “The Favourite,” which attracted our attention with an interesting trailer that preceded “The Crimes
We’ve heard that we should welcome some new subscribers, who aren’t that interested in drug and device litigation, per se, but have been attracted by our coverage of personal jurisdiction issues relating to tort litigation generally. Thanks for joining. Here is a brief description of our available personal jurisdiction resources.
First, we maintain a personal
Happy New Year!
It’s been 3 ½ years since we last updated our index to our online research resources. That’s almost ⅓ of the total life of the blog, which started in way back in 2006. We’ve been blogging now for well over ten years. Our first substantive research post, on the presumption against
Ending the year on a high note is one thing that the blog tries to do – with the top ten drug/device product liability decisions of the year. Occasionally, a court will do something that ruins the party, with an eleventh-hour awful decision (the infamous Bausch v. Stryker Corp., 630 F.3d 546 (7th Cir.
Sometimes it happens. For eleven years, we have published our annual “worst of” the year post on the Thursday before Christmas and our annual “best of” the year post on the Thursday before New Year’s.
Guess what? In a development that we weren’t entirely surprised to see happen, the California Supreme Court recognized not only
The second most successful college basketball coach of all time (in terms of NCAA Division 1 national championships) has said “All of life is peaks and valleys. Don’t let the peaks get too high and the valleys too low.” We’re remembering that today because, frankly, dealing with all the lows at once can get depressing.
Today we’re going peak bagging – no, not to the Canadian Rockies or Patagonia (we leave that to Bexis) – for the high points in this year’s drug/medical device product liability jurisprudence. Last week, we visited the abyss, naming our 2016 Bottom Ten. This week we go in the opposite direction, to the mountaintops.
